Atlas Venture Associates IX, L.P., 10% Owner at Intellia Therapeutics, Inc. (NTLA), sold 40,000 shares at $16.17 ($647K) on 2017-07-10, disclosed to the SEC on 2017-07-11.
Open-market sale of $647k NTLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.